Non random activation of endogenous interleukin-2, (IL-2), IL-2 receptor alpha and IL-2 receptor beta genes after transfection of mouse fibroblasts with a cDNA for the alpha chain of the human IL-2 receptor. 1995

D Han, and S Plaisance, and E Rubinstein, and A Alileche, and C Pottin-Clemenceau, and T S Kim, and E P Cohen, and C Jasmin, and B Azzarone
INSERM U 268, Villejuif, France.

Mouse fibroblasts do not ordinarily express components for the interleukin-2 receptor (IL-2R alpha, beta, and gamma). An analysis of these cells by reverse transcription followed by polymerase chain reaction, however, indicates the presence of transcripts specific for the IL-2R beta and gamma genes. Transfection of the cDNA for the alpha chain of the human IL-2R into LTK- mouse fibroblast cell line (L3 cells) leads, in long-term cultures, to the formation of transcripts of endogenous mouse IL-2, IL-2R alpha and beta genes, as detected by Northern blotting. Based upon the results of the binding of 125I-labeled IL-2 to the transfected cells, three IL-2-binding proteins of 55 kDa, 65 kDa and 75 kDa were expressed by the transfected cells. The 65-kDa and 75-kDa proteins bound IL-2 in the presence of monoclonal antibodies for the IL-2R alpha chain. These polypeptides assembled to form high-affinity IL-2R, as shown by Scatchard binding analyses. The receptors were functionally active, since the expression of H-2k major histocompatibility complex antigens on the surface membranes of L3 cells was enhanced by exposing the cells to IL-2. Activation of the IL-2 gene was also observed in long-term cultures of L alpha beta cells, another LTK- transfectant expressing the human IL-2R alpha chain. This type of gene activation was not observed in LTK- fibroblasts transfected with cDNA for human IL-2 or IL-2R beta genes. In L3 and L alpha beta cells, transcription of the endogenous IL-2 gene was suppressed by cyclosporin A and enhanced by cycloheximide. These data may have implications for gene therapy of cancer cells.

UI MeSH Term Description Entries
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003513 Cycloheximide Antibiotic substance isolated from streptomycin-producing strains of Streptomyces griseus. It acts by inhibiting elongation during protein synthesis. Actidione,Cicloheximide
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D005805 Genes, MHC Class I Genetic loci in the vertebrate major histocompatibility complex which encode polymorphic characteristics not related to immune responsiveness or complement activity, e.g., B loci (chicken), DLA (dog), GPLA (guinea pig), H-2 (mouse), RT-1 (rat), HLA-A, -B, and -C class I genes of man. Class I Genes,Genes, Class I,Genes, H-2 Class I,Genes, HLA Class I,MHC Class I Genes,H-2 Class I Genes,HLA Class I Genes,Class I Gene,Gene, Class I,Genes, H 2 Class I,H 2 Class I Genes
D006183 H-2 Antigens The major group of transplantation antigens in the mouse. H2 Antigens,Antigens, H-2,Antigens, H2,H 2 Antigens
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated

Related Publications

D Han, and S Plaisance, and E Rubinstein, and A Alileche, and C Pottin-Clemenceau, and T S Kim, and E P Cohen, and C Jasmin, and B Azzarone
March 1992, European journal of immunology,
D Han, and S Plaisance, and E Rubinstein, and A Alileche, and C Pottin-Clemenceau, and T S Kim, and E P Cohen, and C Jasmin, and B Azzarone
November 1995, European journal of immunology,
D Han, and S Plaisance, and E Rubinstein, and A Alileche, and C Pottin-Clemenceau, and T S Kim, and E P Cohen, and C Jasmin, and B Azzarone
October 1992, Biochemical and biophysical research communications,
D Han, and S Plaisance, and E Rubinstein, and A Alileche, and C Pottin-Clemenceau, and T S Kim, and E P Cohen, and C Jasmin, and B Azzarone
January 1986, Nature,
D Han, and S Plaisance, and E Rubinstein, and A Alileche, and C Pottin-Clemenceau, and T S Kim, and E P Cohen, and C Jasmin, and B Azzarone
January 1989, Cold Spring Harbor symposia on quantitative biology,
D Han, and S Plaisance, and E Rubinstein, and A Alileche, and C Pottin-Clemenceau, and T S Kim, and E P Cohen, and C Jasmin, and B Azzarone
November 1995, Mammalian genome : official journal of the International Mammalian Genome Society,
D Han, and S Plaisance, and E Rubinstein, and A Alileche, and C Pottin-Clemenceau, and T S Kim, and E P Cohen, and C Jasmin, and B Azzarone
March 2009, Cancer immunology, immunotherapy : CII,
D Han, and S Plaisance, and E Rubinstein, and A Alileche, and C Pottin-Clemenceau, and T S Kim, and E P Cohen, and C Jasmin, and B Azzarone
July 1998, Cytokine,
D Han, and S Plaisance, and E Rubinstein, and A Alileche, and C Pottin-Clemenceau, and T S Kim, and E P Cohen, and C Jasmin, and B Azzarone
November 1991, Journal of immunology (Baltimore, Md. : 1950),
D Han, and S Plaisance, and E Rubinstein, and A Alileche, and C Pottin-Clemenceau, and T S Kim, and E P Cohen, and C Jasmin, and B Azzarone
November 1996, The Journal of biological chemistry,
Copied contents to your clipboard!